LETTER
New Entry to Benzo[4,5]furo[3,2-b]pyridines
79
Clarke, K.; Dumadag, L.; Younger, J.; Ivy, P.; Winer, E. P.
Invest. New Drugs 2007, 25, 161. (c) Brachwitz, K.;
Hilgeroth, A. Bioorg. Med. Chem. Lett. 2002, 12, 411.
(d) Voigt, B.; Meijer, L.; Lozach, O.; Schaechtele, C.;
Totzke, F.; Hilgeroth, A. Bioorg. Med. Chem. Lett. 2005, 15,
823. (e) Xie, Y.; Zhang, G.; Wang, X.; Gray, N. S.; Liu, Y.
WO 2007021795, 2007; Chem. Abstr. 2007, 146, 274386.
(4) Selected examples: (a) Yoon, W. S.; Lee, J. S.; Kang, S. K.;
Ha, D. C.; Ha, J. D. Tetrahedron Lett. 2009, 50, 4492.
(b) Yue, W. S.; Li, J. J. Org. Lett. 2002, 4, 2201.
(c) Mukhanova, T. I.; Alekseeva, L. M.; Kuleshova, E. F.;
Grank, V. G. Mendeleev Commun. 1993, 4, 146. (d) Jaen,
J. C.; Wise, L. D. J. Heterocycl. Chem. 1987, 24, 1317.
(e) Ueki, A.; Kawakubo, H.; Okazaki, K.; Hase, T.
JP 01100172, 1989; Chem. Abstr. 1989, 111, 194745.
(f) Klioze, S. S. EP 100046 A1, 1984; Chem. Abstr. 1984,
101, 55087. (g) Boigegrain, R.; Gachon, M.; Maffrand, J. P.;
Maire, G. DE 2812950, 1979; Chem. Abstr. 1979, 90, 23019.
(5) (a) Iaroshenko, V. O.; Wang, Y.; Zhang, B.; Volochnyuk,
D.; Sosnovskikh, V. Y. Synthesis 2009, 2393.
displayed by that ketone with both 2- and 3-(benzothie-
nyl)iminotriphenylphosphoranes.10a,b
It is worth noting that with the enones 6b–f the outcoming
benzofuropyridines 3b–f were always produced as single
regioisomeric compounds.10a Evidently, the iminophos-
phorane 5 could initially form formal aza-Wittig aza-
hexa-1,3,5-triene intermediates. These intermediates then
underwent thermal electrocyclization eventually leading
to the isolated pyridines 3 after further dehydrogenation of
the cyclized dihydropyridines (Scheme 4). In this respect,
the (benzofuran-3-yl)iminotriphenylphosphorane (5) was
consistent with the benzothienyl and indolyl counterparts
which similarly furnished only aza-Wittig electrocycliza-
tion pyridines in their reactions with enones.10a,11,18
However, the rather peculiar outcome of the iminophos-
phorane 5 reactions with aldehydes 6a–c remains unclear
at this stage. It is possible that in such cases ensuing
hexatriene intermediates were notably prevented from un-
dergoing usual electrocyclization reaction owing to spe-
cial occurrence of inappropriate geometrical isomers.
(b) Iaroshenko, V. O.; Groth, U.; Kryvokhyzha, N. V.;
Obeid, S.; Tolmachev, A. A.; Wesh, T. Synlett 2008, 343.
(c) Degl’Innocenti, A.; Funicello, M.; Scafato, P.; Spagnolo,
P. Tetrahedron Lett. 1997, 38, 2171. (d) Stolle, W. A. W.;
Marcelis, A. T. M.; Koetsier, A.; van der Plas, H. C.
Tetrahedron 1989, 45, 6511.
In conclusion, we have shown that the fairly mild thermal
reaction of simple enones with N-(benzofuran-3-yl)im-
inotriphenylphosphorane (5) can offer a synthetic entry to
virtually unknown benzo[4,5]furo[3,2-b]pyridines, which
should be especially rewarding when using enones ‘acti-
vated’ by a suitable carbonyl substituent attached to the b-
ethylenic carbon.
(6) The 2- and 3-amines derived from electron-rich, five-
membered heteroaromatic compounds usually are highly
unstable compounds, unless electron-withdrawing
substituents are present, and therefore find uncommon
use in synthetic annulation processes.
(7) Tricycle 3a was originally reported in low yield via a
troublesome six-step sequence from an N-(aryloxy)-
pyridinium salt, see: Abramovitch, R. A.; Inbasekaran,
M. N.; Kato, S.; Radzikowska, T. A.; Tomask, P. J. Org.
Chem. 1983, 48, 690.
(8) For leading reviews on the chemistry of iminophosphoranes
and their use in aza-Wittig electrocyclization reactions, see:
(a) Wamhoff, H.; Richard, G.; Stolben, S. Adv. Heterocycl.
Chem. 1995, 64, 159. (b) Molina, P.; Vilaplana, M. J.
Synthesis 1994, 1197. (c) Fresneda, P.; Molina, P. Synlett
2004, 1. (d) Funicello, M.; Spagnolo, P. In Targets in
Heterocyclic Systems, Vol. 8; Attanasi, O. A.; Spinelli, D.,
Eds.; Società Chimica Italiana: Roma, 2004, 274.
(9) Selected examples: (a) Molina, P.; Pastor, A.; Vilaplana,
M. J. J. Org. Chem. 1996, 61, 8094. (b) Kobayashi, T.;
Nitta, M. Chem. Lett. 1981, 1459. (c) Iino, Y.; Nitta, M.
Bull. Chem. Soc. Jpn. 1988, 61, 2235. (d) Molina, P.;
Pastor, A.; Vilaplana, M. J. Tetrahedron Lett. 1993, 34,
3773. (e) Molina, P.; Pastor, A.; Vilaplana, M. J.; Foces-
Foces, C. Tetrahedron 1995, 51, 1265.
Even though pyridine products should predictably arise to
an extent highly dependent upon structural and electronic
features of the starting enones, the present protocol could,
however, find wide synthetic interest owing to prompt
availability of iminophosphorane and enone precursors,
fair flexibility for substituent introduction, and very sim-
ple practical use.
Studies are in progress to fully discover the actual syn-
thetic potential of our protocol through the use of other
(benzofuran-3-yl)iminophosphoranes P-phenyl/methyl-
substituted.19
Acknowledgment
The authors gratefully acknowledge financial support from the Uni-
versity of Basilicata.
(10) (a) Degl’Innocenti, A.; Funicello, M.; Scafato, P.; Spagnolo,
P.; Zanirato, P. J. Chem. Soc., Perkin Trans. 1 1996, 2561.
(b) Bonini, C.; Chiummiento, L.; Funicello, M.; Spagnolo,
P. Tetrahedron 2000, 56, 1517. (c) Bonini, C.; D’Auria, M.;
Funicello, M.; Romaniello, G. Tetrahedron 2002, 58, 3507.
(d) Bonini, C.; Funicello, M.; Scialpi, R.; Spagnolo, P.
Tetrahedron 2003, 59, 7515.
(11) Bonini, C.; Funicello, M.; Spagnolo, P. Synlett 2006, 1574.
(12) Foresti, E.; Spagnolo, P.; Zanirato, P. J. Chem. Soc., Perkin
Trans. 1 1989, 1354.
(13) Tamura, Y.; Chun, M. W.; Kwon, S.; Bayomi, S. M.; Okada,
T.; Ikeda, M. Chem. Pharm. Bull. 1978, 26, 3515.
(14) (a) Unlike aryl azides, the (electron-rich) five-membered
heteroaryl counterparts are usually hardly available from
corresponding amines via diazonium salts. (b) For the first
report of azido-group-transfer reaction with thiophenes and
References and Notes
(1) (a) Kovtunenko, V. O. In Drug Methods Acting on the
Central Nervous System; Perun: Kiev, 1997, 373.
(b) Silvermann, R. B. In The Organic Chemistry of Drug
Design and Drug Action, 2nd ed; Elsevier Academic Press:
New York, 2004, 617.
(2) Wakelin, L. P. G.; Waring, M. J. In Comprehensive
Medicinal Chemistry; Sammes, P. G., Ed.; Pergamon Press:
Oxford, 1990, 703.
(3) (a) Venkat, R. G.; Qi, L.; Pierce, M.; Robbins, P. B.;
Sahasrabudhe, S. R.; Selliah, R. WO 2007076085, 2007;
Chem. Abstr. 2007, 147, 143456. (b) Burstein, H. J.;
Overmoyer, B.; Gelman, R.; Silverman, P.; Savoie, J.;
Synlett 2010, No. 1, 77–80 © Thieme Stuttgart · New York